Contribution
My Lords, Amendment 72, in my name, addresses a straightforward concern: patients being made to wait for assessment or treatment because of an administrative or financial rule when clinically appropriate care could be provided sooner. My amendment would prohibit minimum waiting times imposed across the NHS in England for administrative, financial or capacity-management reasons. It would apply to both commissioners and providers, including through contracts and activity plans. It would protect clinical decisions about when an assessment, investigation or treatment should take place. A patient may need to wait for a clinical reason, but they should not be made to wait because a commissioner has imposed a minimum waiting period to manage budgets or activity.
That is already happening. An investigation published by the British Medical Journal on 9 September found that nearly half of England’s integrated care boards had introduced some form of minimum waiting time. It reported minimum waits of 16 weeks for routine procedures in Shropshire, Telford and Wrekin, and West Yorkshire, and for cataract treatment in south-east London. Can the Minister confirm whether these policies remain in place and whether the Government consider them acceptable when clinically appropriate care can be provided sooner?
The situation is even starker for ADHD and autism assessments. For example, published information from West Yorkshire’s ICB confirms a minimum wait of two years from referral for assessments with independent providers. The ICB says that this is intended to make waiting times fairer and to manage financial pressures, but the central question remains: why require someone to wait two years if an appropriate assessment could be provided sooner? An assessment can help someone understand their difficulties and get appropriate support. A two-year delay can have consequences for their education, employment and family life.
The ICB allows urgent assessments where certain specified clinical criteria are met. Those urgent exceptions are important, but what happens when the criteria are so restrictive that they exclude patients whom clinicians believe are at serious risk? I present this point from a practical perspective. I heard only last week about a concern in another ICB area. Clinicians there identify patients whom they believe are at risk of serious harm, including self-harm and suicide, yet those patients appear to fall outside that ICB’s tightly drawn criteria for urgent assessment. When clinicians raised these concerns, the responses reported include directing patients to NHS 111 and suggesting that referrals could be returned to their GP if the provider is concerned about managing the clinical risks while they wait. Of course, NHS 111 and GPs have important roles in helping patients access urgent support, but that does not answer the clinicians’ concern that these patients need an earlier specialist assessment.
This concerns the restrictions on funded activity rather than a fixed minimum wait time, but it raises a serious question: are urgent criteria being drawn around the available budget rather than the clinical needs of the patient? Surely there must be a prompt clinical review and a clear, funded route to appropriate care for patients whose clinicians identify serious risk, even when they fall outside the ICB’s specified categories.
I recognise that commissioners face very difficult financial choices, but making patients wait when appropriate care is available does not remove their need for care. Their condition may worsen and they may need more help from other services while they wait. I have three concerns about policies that impose these minimum waits: harm to patients, fairness and transparency.
First, on harm to patients, someone waiting for a hip replacement, cataract surgery or diagnostic test may be living with pain, unable to work or drive, or losing their independence. Their life does not go on hold because a waiting time clock has started. If their condition worsens, they may need more help from their GP, social care or emergency services. Meanwhile, capacity that could have been used to treat them sooner may grow unused. How is that a sensible use of NHS resources? In responding to the BMJ investigation, the Royal College of Surgeons warned about deliberately delaying patients who are ready for treatment. The Royal College of General Practitioners also questioned blanket minimum waits while patients could be treated sooner.
Secondly, on fairness, access to care should depend on clinical need, yet a patient in one ICB area may be required to wait at least 16 weeks while someone with the same needs in a neighbouring ICB area faces no such rule. Surely that is the definition of a postcode lottery. What does “patient choice” mean if someone chooses an appropriate provider who could see them sooner but a commissioning rule prevents it?
Thirdly, there is transparency. In Written Answers to Dr Luke Evans MP on 22 June, the Government said there was
“no formal national policy supporting minimum waits”,
but they confirmed that the NHS standard contract allowed local commissioners to set what they called “activity planning assumptions”. Whatever the label we use, if a contractual rule stops a patient receiving care sooner, its effect must surely be open to scrutiny. Yet the Government also said that NHS England did not collect information on which ICBs impose minimum waits, which services were affected or their impact. How can the Government judge these policies without that information? Patients should know why they are waiting and be able to challenge a rule that unnecessarily delays their care.